Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerry Coghlan

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Basic Research in Cardiology|April 23, 2022
Effects of late, repetitive remote ischaemic conditioning on myocardial strain in patients with acute myocardial infarctionJ Ranjit Arnold, Andrew P Vanezis, Glenn C Rodrigo, et al.
Advances in Therapy|November 2, 2021
Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label ExtensionNazzareno Galiè, Sean Gaine, Richard Channick, et al.
Arthritis Research & Therapy|October 28, 2019
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)Zixuan Pan, Alberto M Marra, Nicola Benjamin, et al.
The European Respiratory Journal|August 19, 2017
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertensionSean Gaine, Kelly Chin, Gerry Coghlan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 26, 2023
Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society GuidelinesOliver Distler, Diana Bonderman, J Gerry Coghlan, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 8, 2018
Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON StudyJ Gerry Coghlan, Richard Channick, Kelly Chin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery PressureChristian Nagel, Alberto M Marra, Nicola Benjamin, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyJ Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, et al.
Pulmonary Circulation|December 6, 2021
Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacyMartin R Wilkins, Mikel A Mckie, Martin Law, et al.
American Journal of Respiratory and Critical Care Medicine|October 22, 2008
Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment eraRobin Condliffe, David G Kiely, Andrew J Peacock, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Basic Research in Cardiology|April 23, 2022
Effects of late, repetitive remote ischaemic conditioning on myocardial strain in patients with acute myocardial infarctionJ Ranjit Arnold, Andrew P Vanezis, Glenn C Rodrigo, et al.
Advances in Therapy|November 2, 2021
Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label ExtensionNazzareno Galiè, Sean Gaine, Richard Channick, et al.
Arthritis Research & Therapy|October 28, 2019
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)Zixuan Pan, Alberto M Marra, Nicola Benjamin, et al.
The European Respiratory Journal|August 19, 2017
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertensionSean Gaine, Kelly Chin, Gerry Coghlan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 26, 2023
Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society GuidelinesOliver Distler, Diana Bonderman, J Gerry Coghlan, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 8, 2018
Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON StudyJ Gerry Coghlan, Richard Channick, Kelly Chin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery PressureChristian Nagel, Alberto M Marra, Nicola Benjamin, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyJ Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, et al.
Pulmonary Circulation|December 6, 2021
Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacyMartin R Wilkins, Mikel A Mckie, Martin Law, et al.
American Journal of Respiratory and Critical Care Medicine|October 22, 2008
Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment eraRobin Condliffe, David G Kiely, Andrew J Peacock, et al.
Pageof 11